Review
Published on 29 May 2024
State-of-the-art cytometry in the search of novel biomarkers in digestive cancers
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1407580
- 1,863 views
- 2 citations
Type at least 3 characters
1,407 articles
Systematic Review
Published on 24 May 2024
Can adjuvant immune checkpoint inhibitors improve the long-term outcomes of hepatocellular carcinoma with high-risk recurrent factors after liver resection? A meta-analysis and systematic review
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1374262
- 1,153 views
Case Report
Published on 24 May 2024
Case report: Regression after low-dose glucocorticoid therapy in a case of acute immune myocarditis induced by anti-PD-1 therapy for NSCLC
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1404045
- 1,310 views
- 1 citation
Systematic Review
Published on 17 May 2024
Treatment-related adverse events of immune checkpoint inhibitors in clinical trials: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1391724
- 1,563 views
- 5 citations
Systematic Review
Published on 16 May 2024
Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1385761
- 2,220 views
Hypothesis and Theory
Published on 14 May 2024
Porphyromonas gingivalis, a bridge between oral health and immune evasion in gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1403089
- 3,741 views
- 4 citations
Mini Review
Published on 10 May 2024
The role of neck adipose tissue in lymph node metastasis of head and neck cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1390824
- 1,648 views
Case Report
Published on 10 May 2024
Case report: Regression of in-transit metastases of cutaneous squamous cell carcinoma with combination pembrolizumab and topical diphencyprone
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1294331
- 1,244 views
Case Report
Published on 10 May 2024
Case report: Long-term intracranial effect of zimberelimab monotherapy following surgical resection of high PD-L1-expressing brain metastases from NSCLC
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1390343
- 1,126 views
- 1 citation
Case Report
Published on 10 May 2024
Case report: Massive hepatocellular carcinoma with complete response to the non-surgical systematic treatment strategy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1291131
- 1,681 views
Original Research
Published on 08 May 2024
Examination of the role of mutualism in immune evasion
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1406744
- 990 views
- 1 citation
Systematic Review
Published on 02 May 2024
The risk of endocrine immune-related adverse events induced by PD-1 inhibitors in cancer patients: a systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1381250
- 3,018 views
- 2 citations
Original Research
Published on 02 May 2024
Increased co-expression of 4-1BB with PD-1 on CD8+ tumor-infiltrating lymphocytes is associated with improved prognosis and immunotherapy response in cervical cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1381381
- 1,871 views
- 1 citation
Original Research
Published on 02 May 2024
Predictive value of PD-L1 and TMB for short-term efficacy prognosis in non-small cell lung cancer and construction of prediction models
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1342262
- 1,577 views
Original Research
Published on 01 May 2024
High immune cell infiltration predicts improved survival in cholangiocarcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1333926
- 1,478 views
- 4 citations
Original Research
Published on 29 Apr 2024
Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2024.1376622
- 2,368 views